A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light

Transfusion

Volumn 49, Issue 12, 2009, Pages 2612-2624

  Mohr, Harald ^a,b   Steil, Leif ^a,b   Gravemann, Ute ^a,b   Thiele, Thomas ^a,b   Hammer, Elke ^a,b   Greinacher, Andreas ^a,b   Müller, Thomas H ^a,b   Völker, Uwe ^a,b  

^a Institute Springe   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCOSE; LACTIC ACID; LIPOCORTIN 5; THROMBOCYTE CONCENTRATE;

ARTICLE; BACILLUS CEREUS; BACTERIUM; BACTERIUM ISOLATE; BLOOD DONOR; BLOOD STORAGE; CELL ISOLATION; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; ESCHERICHIA COLI; GAMMA IRRADIATION; GEL ELECTROPHORESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOOSMOTIC STRESS; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; KLEBSIELLA PNEUMONIAE; LIGHT ABSORPTION; MICROBIOLOGICAL PARAMETERS; NONHUMAN; PATHOGEN REDUCTION; PH MEASUREMENT; PORCINE PARVOVIRUS; PROTEOMICS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTE AGGREGATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; ULTRAVIOLET RADIATION; VERO CELL; VIRUS; VIRUS ISOLATION; WEST NILE FLAVIVIRUS;

BACTEREMIA; BACTERIA; BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; MODELS, BIOLOGICAL; PLATELETPHERESIS; PROTEOME; STERILIZATION; ULTRAVIOLET RAYS; VIREMIA; VIRUSES;

EID: 71849108754     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02334.x     Document Type: Article

References (61)

1. Klein HG. Pathogen inactivation technology: cleansing the blood supply. J Intern Med 2005 257 : 224 37.
2. Blajchman MA, Goldman M, Baeza F. Improving the bacteriological safety of platelet transfusions. Transfus Med Rev 2004 18 : 11 24.
3. Larsen CP, Ezligini F, Hermansen NO, Kjeldsen-Kragh J. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005 88 : 93 7.
4. de Korte D, Curvers J, de Kort WL, Hoekstra T, van der Poel CL, Beckers EA, Marcelis JH. Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006 46 : 476 85.
5. Ramirez-Arcos S, Jenkins C, Dion J, Bernier F, Delage G, Goldman M. Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007 47 : 421 9.
6. Eder AF, Kennedy JM, Dy BA, Notari EP, Weiss JW, Fang CT, Wagner S, Dodd RY, Benjamin RJ. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007 47 : 1134 42.
7. Murphy WG, Foley M, Doherty C, Tierney G, Kinsella A, Salami A, Cadden E, Coakley P. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008 95 : 13 9.
8. Benjamin RJ, Wagner SJ. The residual risk of sepsis: modeling the effect of concentration on bacterial detection in two-bottle culture systems and an estimation of false-negative culture rates. Transfusion 2007 47 : 1381 9.
9. Alter AJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol 2007 44 : 32 41.
10. Bianco C. Dengue and Chikungunya viruses in blood donations: risks to the blood supply? Transfusion 2008 48 : 1279 81.
11. Webert KE, Cserti CM, Hannon J, Lin Y, Pavenski K, Pendergrast JM, Blajchman MA. Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies. Transfus Med Rev 2008 22 : 1 34.
12. Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behrman B, Cimino GD, Corten L, Damonte PB, Dikeman R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Metchette K, Nerio AT, Pu JT, Reames AA, Rheinschmidt M, Tessman J, Isaacs ST, Wollowitz S, Corash L. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997 37 : 423 35.
13. Goodrich RP. The use of riboflavin for the inactivation of pathogens in blood products. Vox Sang. 2000 78 Suppl 2 : 211 5.
14. Ciaravi V, McCullough T, Dayan AD. Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets. Hum Exp Toxicol 2001 20 : 533 50.
15. Kallenbach NR, Cornelius PA, Negus D, Montgomerie D, Englander S. Inactivation of viruses by ultraviolet light. Curr Stud Hematol Blood Transfus 1989 56 : 70 82.
16. Sinha RP, Hader DP. UV-induced DNA damage and repair: a review. Photochem Photobiol Sci 2002 1 : 225 36.
17. Cadet J, Sage E, Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005 571 : 3 17. (Pubitemid 40313428)
18. Douki T, Laporte G, Cadet J. Inter-strand photoproducts are produced in high yield within A-DNA exposed to UVC radiation. Nucleic Acids Res 2003 31 : 3134 42.
19. Rodrigo G, Roumagnac S, Wold MS, Salles B, Calsou P. DNA replication but not nucleotide excision repair is required for UVC-induced replication protein A phosphorylation in mammalian cells. Mol Cell Biol 2000 20 : 2696 705.
20. Sanz EN, Dávila LS, Balao JA, Alonso JM. Modelling of reactivation after UV disinfection: effect of UV-C dose on subsequent photoreactivation and dark repair. Water Res 2007 41 : 3141 51.
21. Hart H, Reid K, Hart W. Inactivation of viruses during ultraviolet light treatment of human intravenous immunoglobulin and albumin. Vox Sang 1993 64 : 82 8.
22. Chin S, Williams B, Gottlieb P, Margolis-Nunno H, Ben-Hur E, Hamman J, Jin R, Dubovi E, Horowitz B. Virucidal short wavelength ultraviolet light treatment of plasma and factor VIII concentrate: protection of proteins by antioxidants. Blood 1995 86 : 4331 6.
23. Caillet-Fauquet P, Di Giambattista M, Draps ML, Sandras F, Branckaert T, de Launoit Y, Laub R. Continuous-flow UVC irradiation: a new, effective, protein activity-preserving system for inactivating bacteria and viruses, including erythrovirus B19. J Virol Methods 2004 118 : 131 9.
24. Thiele T, Steil L, Volker U, Greinacher A. Proteomics of blood-based therapeutics: a promising tool for quality assurance in transfusion medicine. BioDrugs 2007 21 : 179 93.
25. Thiele T, Steil L, Gebhard S, Scharf C, Hammer E, Brigulla M, Lubenow N, Clemetson KJ, Volker U, Greinacher A. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 2007 47 : 1221 33.
26. Orlin JB, Ellis MH. Transfusion-associated graft-versus-host disease. Curr Opin Hematol 1997 4 : 442 8.
27. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 337 : 1861 9.
28. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Haemotherapie), gemäß Transfusionsgesetz der Bundesärztekammer und des Paul-Ehrlich-Instituts. Koeln : Deutscher Aerzteverlag 2005.
29. Eriksson L, Shanwell A, Gulliksson H, Hogman CF, Svensson LA, Kristensen J, Berg B. Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies. Vox Sang 1993 64 : 133 8.
30. Gulliksson H, Larsson S, Kumlien G, Shanwell A. Storage of platelets in additive solutions: effects of phosphate. Vox Sang 2000 78 : 176 84. (Pubitemid 30248957)
31. Mohr H, Tolksdorf F, Walker W, Müller TH. Polyolefinacetate bags for photodynamic treatment and for storage of platelet concentrates. Vox Sang 2004 87 Suppl 3 : S17 92.
32. Brecher ME, Hay SN, Rothenberg SJ. Validation of BacT/Alert plastic culture bottles for use in testing of whole-blood-derived leukoreduced platelet-rich-plasma-derived platelets. Transfusion 2004 44 : 1174 8.
33. Kaerber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1931 162 : 480 3.
34. Spearman C. The method of "right and wrong cases" ("constant stimuli") without Gauss's formulae. Br J Psychol 1908 88 : 227 42.
35. Fantl P. Osmotic stability of blood platelets. J Physiol 1968 198 : 1 16.
36. Brigulla M, Thiele T, Scharf C, Breitner-Ruddock S, Venz S, Volker U, Greinacher A. Proteomics as a tool for assessment of therapeutics in transfusion medicine: evaluation of prothrombin complex concentrates. Transfusion 2006 46 : 377 85.
37. Capon SM, Sacher RA, Deeg HJ. Effective ultraviolet irradiation of platelet concentrates in teflon bags. Transfusion 1990 30 : 678 81.
38. Zimmer JL, Slawson RM. Potential repair of Escherichia coli DNA following exposure to UV radiation from both medium- and low-pressure UV sources used in drinking water treatment. Appl Environ Microbiol 2002 68 : 3293 9.
39. Hijnen WA, Beerendonk EF, Medema GJ. Inactivation credit of UV radiation for viruses, bacteria and protozoan (oo)cysts in water: a review. Water Res 2005 40 : 3 22.
40. Setlow P. Resistance of spores of Bacillus species to ultraviolet light. Environ Mol Mutagen 2001 38 : 97 104.
41. Radziszewska E, Piwocka K, Skierski J, Sikora E. UVC-induced cell death of IL-2-dependent human lymphocytes. Cell Biol Int 1999 23 : 97 103.
42. Morison WL, Parrish JA, McAuliffe DJ, Bloch KJ. Sensitivity of mononuclear cells to UV radiation: effect on subsequent stimulation with phytohemagglutinin. Photochem Photobiol 1980 32 : 99 101.
43. Lankinen MH, Vilpo LM, Vilpo JA. UV- and gamma-induced DNA single-strand breaks and their repair in human blood granulocytes and lymphocytes. Mutat Res 1996 352 : 31 8.
44. Reddy MC, Vasquez KM. Repair of genome stabilizing lesions. Rad Res 2005 164 : 345 56.
45. Terpstra FG, van 't Wout AB, Schuitemaker H, van Engelenburg FA, Dekkers DW, Verhaar R, de Korte D, Verhoeven AJ. Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates. Transfusion 2008 48 : 304 13.
46. Saleh SM, Poidinger M, Mackenzie JS, Broom AK, Lindsay MD, Hall RA. Complete genomic sequence of the Australian south-west genotype of Sindbis virus: comparisons with other Sindbis strains and identification of a unique deletion in the 3′-untranslated region. Virus Genes 2003 26 : 317 27.
47. Lawson ND, Stillman EA, Whitt MA, Rose JK. Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci U S A 1995 92 : 4477 81.
48. Brinton MA. The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol 2002 56 : 371 402.
49. Klupp BG, Hengartner CJ, Mettenleiter TC, Enquist LW. Complete, annotated sequence of the pseudorabies virus genome. J Virol 2004 78 : 424 40.
50. Lytle CD, Sacripanti JL. Predicted inactivation of viruses of relevance to biodefence by solar radiation. J Virol 2005 29 : 14244 52.
51. Henderson EE, Tudor G, Yang JY. Inactivation of the human immunodeficiency virus type 1 (HIV-1) by ultraviolet and X irradiation. Radiat Res 1992 169 76.
52. Mohr H. Inactivation of viruses in human plasma. Methods Enzymol 2000 319 : 207 16.
53. Lambrecht B, Norley SG, Kurth R, Mohr H. Rapid inactivation of HIV-1 in single donor preparations of human fresh frozen plasma by methylene blue/light treatment. Biologicals 1994 22 : 227 31.
54. Mohr H, Knüver-Hopf J, Gravemann U, Redecker-Klein A, Müller TH. West Nile virus in plasma is highly sensitive to methylene blue-light treatment. Transfusion 2005 45 : 886 90.
55. Pamphilon DH, Corbin SA, Saunders J, Tandy NP. Applications of ultraviolet light in the preparation of platelet concentrates. Transfusion 1989 29 : 379 83.
56. Grijzenhout MA, Aarts-Riemens MI, Akkerman JW, Nieuwenhuis HK, van Weelden H, van Prooijen HC. Ultraviolet-B irradiation of platelets induces a dose-dependent increase in the expression of platelet activation markers with storage. Br J Haematol 1993 83 : 627 32.
57. Li J, Goodrich L, Hansen E, Edrich R, Gampp D, Goodrich RP. Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage. Transfusion 2005 45 : 1750 8.
58. Zimmermann R, Schmidt S, Zingsem J, Glaser A, Weisbach V, Ruf A, Eckstein R. Effect of gamma radiation on the in vitro aggregability of WBC-reduced apheresis platelets. Transfusion 2001 41 : 236 42.
59. Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns Adu P. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006 90 : 279 85.
60. Verhaar R, Dekkers DW, De Cuyper IM, Ginsberg MH, de Korte D, Verhoeven AJ. UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3. Blood 2008 112 : 4935 9.
61. Thon JN, Schubert P, Duguay M, Serrano K, Lin S, Kast J, Devine DV. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008 48 : 425 35.